Iti Pharma And Healthcare Fund Datagrid
Category Sectoral/ Thematic
BMSMONEY Rank 8
Rating
Growth Option 15-06-2026
NAV ₹16.61(R) -0.44% ₹18.21(D) -0.42%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 1.39% 18.54% -% -% -%
Direct 3.29% 20.79% -% -% -%
Nifty 500 TRI 0.03% 13.59% 12.06% 14.49% 14.04%
SIP (XIRR) Regular 7.5% 10.24% -% -% -%
Direct 9.45% 12.38% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
0.71 0.35 0.69 6.11% -0.49
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
16.37% -23.79% -16.32% 0.83 11.93%
Fund AUM As on: 30/12/2025 230 Cr
Top Sectoral/ Thematic
Fund Name Rank Rating
Aditya Birla Sun Life Special Opportunities Fund 1
Icici Prudential India Opportunities Fund 2
SBI Comma Fund 3
ICICI Prudential Business Cycle Fund 4
Icici Prudential Commodities Fund 5

NAV Date: 15-06-2026

Scheme Name NAV Rupee Change Percent Change
ITI Pharma and Healthcare Fund - Regular Plan - IDCW Option 16.61
-0.0700
-0.4400%
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option 16.61
-0.0700
-0.4400%
ITI Pharma and Healthcare Fund - Direct Plan - Growth Option 18.21
-0.0800
-0.4200%
ITI Pharma and Healthcare Fund - Direct Plan - IDCW Option 18.21
-0.0800
-0.4200%

Review Date: 15-06-2026

Beginning of Analysis

ITI Pharma and Healthcare Fund is the 12th ranked fund in the Sectoral/ Thematic Fund category. The category has total 22 funds. The 3 star rating shows an average past performance of the ITI Pharma and Healthcare Fund in Sectoral/ Thematic Fund. The fund has a Jensen Alpha of 6.11% which is higher than the category average of 1.34%. Here the fund has shown very good performance in terms of risk adjusted returns. The fund has a Sharpe Ratio of 0.71 which is higher than the category average of 0.53.
The past performance of the fund may or may not be sustained in the future. The review is not investment advice nor is it a recommendation to buy or sell funds. The ranking is based on proprietary methodology developed by bmsmoney. The methodology is based on the past performance of the funds and does not guarantee future performance.
Sectoral/Thematic Mutual Funds are ideal for aggressive investors seeking high returns by investing in a specific sector or theme. These funds offer targeted exposure to sectors like banking, technology, or themes like infrastructure and ESG, allowing investors to capitalize on the growth potential of these segments. However, they carry higher risks due to their concentrated exposure and are heavily dependent on the performance of the chosen sector or theme. Investors should have a long-term investment horizon, a high risk tolerance, and a good understanding of the sector or theme before investing in these funds. Additionally, timing the market and monitoring sectoral trends are crucial for success.

ITI Pharma and Healthcare Fund Return Analysis

The ITI Pharma and Healthcare Fund has delivered a mixed performance across various time horizons, showcasing both strengths and challenges when compared to its Sectoral/ Thematic Fund peers and the Nifty 500 TRI benchmark. This analysis examines the fund’s returns over periods ranging from one month to ten years, alongside its Systematic Investment Plan (SIP) performance, highlighting its rankings within the Sectoral/ Thematic Fund category and its ability to outperform or underperform the benchmark and category averages.

  • The fund has given a return of -0.49%, 11.89 and 5.87 in last one, three and six months respectively. In the same period the category average return was 2.11%, 10.21% and 1.21% respectively.
  • ITI Pharma and Healthcare Fund has given a return of 3.29% in last one year. In the same period the Nifty 500 TRI return was 0.03%. The fund has given 3.26% more return than the benchmark return.
  • The fund has given a return of 20.79% in last three years and rank 4th out of twenty three funds in the category. In the same period the Nifty 500 TRI return was 13.59%. The fund has given 7.2% more return than the benchmark return.
  • The fund has given a SIP return of 9.45% in last one year whereas category average SIP return is 6.71%. The fund one year return rank in the category is 16th in 40 funds
  • The fund has SIP return of 12.38% in last three years and ranks 7th in 22 funds. HDFC Defence Fund has given the highest SIP return (31.21%) in the category in last three years.

ITI Pharma and Healthcare Fund Risk Analysis

  • The fund has a standard deviation of 16.37 and semi deviation of 11.93. The category average standard deviation is 15.08 and semi deviation is 11.51.
  • The fund has a Value at Risk (VaR) of -23.79 and a maximum drawdown of -16.32. The category average VaR is -23.34 and the maximum drawdown is -18.57. The fund has a beta of 0.87 which shows that fund is less volatile than the benchmark.

Standard deviation measures the fund's return volatility and Semi deviation focuses on downside volatility. Value at Risk (VaR) is a measure of the risk of investments. Maximum Drawdown is the maximum loss from a peak to a trough of a portfolio. Beta measures the volatility of the fund compared to the benchmark. A beta of 1 indicates that the fund will move in line with the benchmark. A beta of more than 1 indicates that the fund will be more volatile than the benchmark and vice versa.


  • Very Good Performance in Sectoral/ Thematic Fund Category
  • Good Performance in Sectoral/ Thematic Fund Category
  • Poor Performance in Sectoral/ Thematic Fund Category
  • Very Poor Performance in Sectoral/ Thematic Fund Category

    • Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

    Data Source: www.amfiindia.com

    SEBI Categorization


    KPIs* Fund Nifty 500 TRI Cat. Avg Min | Max Rank (In Cat.) Performance
    1M Return % -0.63 1.73
    2.06
    		-1.64 | 7.21 45 | 50 Poor
    3M Return % 11.40 6.70
    10.04
    		1.11 | 26.35 17 | 50 Good
    6M Return % 4.91 -3.19
    0.76
    		-8.29 | 23.60 12 | 50 Very Good
    1Y Return % 1.39 0.03
    3.58
    		-7.17 | 25.51 18 | 41 Good
    3Y Return % 18.54 13.59
    16.00
    		5.56 | 40.93 5 | 23 Very Good
    1Y SIP Return % 7.50
    5.82
    		-9.54 | 29.56 16 | 39 Good
    3Y SIP Return % 10.24
    8.39
    		-1.69 | 29.79 7 | 22 Good
    Standard Deviation 16.37
    15.08
    		12.56 | 17.98 18 | 23 Average
    Semi Deviation 11.93
    11.51
    		9.54 | 14.14 18 | 23 Average
    Max Drawdown % -16.32
    -18.57
    		-25.37 | -12.71 6 | 23 Very Good
    VaR 1 Y % -23.79
    -23.34
    		-32.34 | -16.03 12 | 23 Good
    Average Drawdown % -7.62
    -7.84
    		-11.12 | -5.66 12 | 23 Good
    Sharpe Ratio 0.71
    0.53
    		0.08 | 0.98 8 | 23 Good
    Sterling Ratio 0.69
    0.51
    		0.21 | 0.85 4 | 23 Very Good
    Sortino Ratio 0.35
    0.25
    		0.06 | 0.45 6 | 23 Very Good
    Jensen Alpha % 6.11
    1.34
    		-5.75 | 8.79 3 | 23 Very Good
    Treynor Ratio -0.49
    -0.45
    		-0.54 | -0.34 18 | 23 Average
    Modigliani Square Measure % 16.76
    13.97
    		7.02 | 21.00 8 | 23 Good
    Alpha % 4.89
    1.28
    		-5.39 | 10.56 6 | 23 Very Good
    Return data last Updated On : June 15, 2026.
    Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : March 30, 2026
    KPIs: Key Performance Indicators

    Rotate the phone! Best viewed in landscape mode on mobile.
    KPIs* Fund Nifty 500 TRI Cat. Avg Min | Max Rank (In Cat.) Performance
    1M Return % -0.49 1.73 2.11 -1.61 | 7.33 45 | 51 Poor
    3M Return % 11.89 6.70 10.21 1.50 | 26.74 17 | 51 Good
    6M Return % 5.87 -3.19 1.21 -7.74 | 24.21 12 | 51 Very Good
    1Y Return % 3.29 0.03 4.69 -6.03 | 26.82 17 | 42 Good
    3Y Return % 20.79 13.59 17.31 6.86 | 42.51 4 | 23 Very Good
    1Y SIP Return % 9.45 6.71 -8.44 | 30.36 16 | 40 Good
    3Y SIP Return % 12.38 9.62 -0.42 | 31.21 7 | 22 Good
    Standard Deviation 16.37 15.08 12.56 | 17.98 18 | 23 Average
    Semi Deviation 11.93 11.51 9.54 | 14.14 18 | 23 Average
    Max Drawdown % -16.32 -18.57 -25.37 | -12.71 6 | 23 Very Good
    VaR 1 Y % -23.79 -23.34 -32.34 | -16.03 12 | 23 Good
    Average Drawdown % -7.62 -7.84 -11.12 | -5.66 12 | 23 Good
    Sharpe Ratio 0.71 0.53 0.08 | 0.98 8 | 23 Good
    Sterling Ratio 0.69 0.51 0.21 | 0.85 4 | 23 Very Good
    Sortino Ratio 0.35 0.25 0.06 | 0.45 6 | 23 Very Good
    Jensen Alpha % 6.11 1.34 -5.75 | 8.79 3 | 23 Very Good
    Treynor Ratio -0.49 -0.45 -0.54 | -0.34 18 | 23 Average
    Modigliani Square Measure % 16.76 13.97 7.02 | 21.00 8 | 23 Good
    Alpha % 4.89 1.28 -5.39 | 10.56 6 | 23 Very Good
    Return data last Updated On : June 15, 2026.
    Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : March 30, 2026
    KPIs: Key Performance Indicators

    Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


    Date Iti Pharma And Healthcare Fund NAV Regular Growth Iti Pharma And Healthcare Fund NAV Direct Growth
    15-06-2026 16.6107 18.2125
    12-06-2026 16.6838 18.2901
    11-06-2026 16.5847 18.1806
    10-06-2026 16.5767 18.1711
    09-06-2026 16.6743 18.2772
    08-06-2026 16.51 18.0963
    05-06-2026 16.5316 18.1174
    04-06-2026 16.4349 18.0105
    03-06-2026 16.378 17.9474
    02-06-2026 16.2897 17.8498
    01-06-2026 16.3902 17.9591
    29-05-2026 16.4949 18.0712
    27-05-2026 16.6848 18.2776
    26-05-2026 16.6992 18.2925
    25-05-2026 16.7611 18.3595
    22-05-2026 16.7003 18.2903
    21-05-2026 16.8825 18.4889
    20-05-2026 16.8275 18.4279
    19-05-2026 16.802 18.3991
    18-05-2026 16.7302 18.3196
    15-05-2026 16.7165 18.3022

    Fund Launch Date: 17/Nov/2021
    Fund Category: Sectoral/ Thematic
    Investment Objective: The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.
    Fund Description: An open ended equity scheme investing in Pharma and Healthcare
    Fund Benchmark: Nifty Healthcare Total Return Index
    Source: Fund FactSheet

    Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.